. The South East Network for Social Sciences (SeNSS) offers funding of up to £20,000 per year for you to undertake postgraduate studies, starting in October 2023. Read more
. The South East Network for Social Sciences (SeNSS) offers funding of up to £20,000 per year for you to undertake postgraduate studies, starting in October 2023. Read more
. Combining the vocational training of a medical degree with the research expertise of a PhD. The Kennedy Trust IMPACT Inflammation MB-PhD is a funded three-year programme aimed at undergraduate medical students who wish to train as clinician scientists. Read more
Bring your research to life at UEA. As a Postgraduate Research student at UEA, you'll join a world-leading research-intensive university where PhD students are not just researchers, but junior academics. Read more
Exogenous corticosteroids (dexamethasone) are standard of care for patients with COVID-19 and have been shown to cut mortality by up to 30% in acutely ill patients. Read more
Bronchiectasis is a chronic inflammatory disease characterised by persistent neutrophilic inflammation in the airways. The disease is common worldwide but particularly in Asia where it is a common complication of tuberculosis. Read more
It is well established that certain “good bacteria” in the gut maintain health and promote normal immune tone. Similar concepts likely apply to the airway but to date the normal beneficial commensal microbiota have not been well described. Read more
Cathepsin-C (also known as dipeptidyl peptidase-1) is an enzyme involved in the activation of neutrophil serine proteases such as neutrophil elastase, proteinase-3 and cathepsin-G. Read more
Neutrophils are the key first responders in acute and chronic respiratory infections but currently there are no drugs which directly target neutrophils. Read more
P. aeruginosa infection classically leads to a proinflammatory Th1 and neutrophil mediated inflammatory response. Some data suggest, however, that P. Read more
Neutrophils are the key first responders in acute and chronic respiratory infections but currently there are no drugs which directly target neutrophilic inflammation. Read more
New antibiotics are needed to treat antibiotic resistant pathogens such as P. aeruginosa which is a major driver of morbidity and mortality in cystic fibrosis and bronchiectasis. Read more
The outcome of viral infection in humans varies from asymptomatic infection to fatal acute respiratory distress syndrome. This variation is explained by differences in the host response to infection. Read more
*Offer only available for the duration of your active subscription, and subject to change. You MUST claim your prize within 72 hours, if not we will redraw.
Create your myFindAPhD account to add this PhD to your shortlist to register for this event to receive updates on upcoming events
Due to your Facebook privacy settings, we were unable to create your account at this time. Please select another method to sign up.
We were unable to log you in with your Google account at this time. If you have third-party cookies blocked, please enable them, refresh, and try again.
We were unable to log you in with your Google account at this time. If you have third-party cookies blocked, please enable them, refresh, and try again.
Continue with Facebook
Looking to list your PhD opportunities? Log in here.